Radiation Oncology

Lyndsay Harshman's (11MD, 14F, 18MS) path to #PediatricNephrology wasn’t a straight one, but it led her to a career of meaningful research and pediatric clinical care. “When opportunities come up, you have to be willing to just take the dive,” she says. spr.ly/6012Q6Gwp

Congratulations Andrean Simons-Burnett, PhD, recipient of a $1.7M R01 grant from @NIDCR. The award will support her project which seeks to understand how drug resistance to targeted therapy occurs and develop new strategies to allow these therapies to work.

How does drug resistance to targeted therapy occur, and how do you find new strategies to make the therapy work? Congratulations to Andrean Simons-Burnett, PhD and her lab for winning an R01 grant (Inflammation and EGFR crosstalk in HNSCC Therapy) to probe these questions!

High-dose, IV vitamin C doubles survival for patients in chemotherapy for late-stage pancreatic cancer, according to a clinical trial. "The results were so strong that we were able to stop the trial early,” says senior author Joe Cullen, MD, of @IowaRadOnc spr.ly/6017s8gEL

Suryamin (Michael) Liman successfully defended his thesis (Carbon Monoxide Activates Heme Metabolism to Improve Cartilage Health After Intraarticular Injury or Surgical Exposure), and becomes our newest minted FRRBP PhD. Congrats to Mike!

For the fourth year in a row, @IowaRadOnc was awarded the Outstanding Patient Experience Team Award by the Office of the Patient Experience. This places us in the top 10% of providers nationwide. Kudos to consistent care! 🎉

New publication! 🧪✨ Our study explores how combining Cu-ATSM with RT boosts survival effects in DIPG cells, paving the way for innovative approaches against this tough-to-treat pediatric cancer. @RadiatRes! 🔗 doi.org/10.1667/RADE-2… #CancerResearch #DIPG #PediatricCancer

Congratulations to James Byrne, MD, PhD, recipient of the $1.5-million @NIH Director’s New Innovator Award to support the development of novel biocompatible materials to reduce the side effects of radiation therapy. #NIHHighRisk @NIH_CommonFund @IowaRadOnc spr.ly/6011UU5zL

With high risk comes high reward: huge congratulations to James Byrne MD, PhD, one of the 2024 winners of the NIH Director’s New Innovator Award. bit.ly/Byrne-innovator.

James Byrne MD, PhD earns a spot on @IowaMed Wall of Scholarship for his paper “Active targeting schemes for nanoparticle systems in cancer therapeutics”, with over 1000 citations on 3 indices!

@IowaRadOnc congratulates Ryan Courtney and Gizzy Keeler on their quality research presented at the Medical Student Research Conference. Ryan won the Larry B. Oberley Award in Radiation Oncology.

@IowaRadOnc and @IowaRad making a splash with Theranostics research.

Hakes: A first-person look at radiation therapy and the masks that help kids cope press-citizen.com/story/news/loc… via @presscitizen

Abdominal compression: @DrJoelStA and co-authors discuss another tool to restrict tumor motion without gating or breath hold in @FrontOncology bit.ly/abdom_comp #pancreatic_cancer, #Elekta Unity MR Linac

In #radiotherapy there are sites that are particularly challenging to visualize where you want to manage motion. Read how @IowaRadOnc is using surrogate gating strategies with Elekta Unity to track moving targets for lung, liver, pancreas and prostate ➡️ bit.ly/3Yz3VIZ

Calling all Med Students! @IowaRadOnc Virtual Meet and Greet: September 9 (bit.ly/Sept-9) and 23 (bit.ly/Sept-23) @ 5pm-6pm Central.

Way to go Howard lab! 👍

A simple method for performing Patient Specific Quality Assurance measurements on laterally located liver and lung tumors: bit.ly/MRLinac_QA, #MRLinac, #Elekta, #QualityAssured

Dynamic Collimation System for Proton Therapy getting some eyeballs at #AAPM2024.

@AndersonCarryn announced as @ASTRO_org Fellow for 2024. Tremendous accolade! #FASTRO 👏